Difference between revisions of "Dolasetron (Anzemet)"
Jump to navigation
Jump to search
Warner-admin (talk | contribs) m (Text replacement - "Category:Drug index" to "Category:Drugs") |
m (→Also known as) |
||
| (2 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
==Mechanism of action== | ==Mechanism of action== | ||
5-HT3 antagonist | 5-HT3 antagonist | ||
| + | |||
| + | ==Also known as== | ||
| + | *'''Generic name:''' dolasetron mesylate | ||
| + | *'''Brand name:''' Anzemet | ||
[[Category:Drugs]] | [[Category:Drugs]] | ||
| + | [[Category:Intravenous medications]] | ||
| + | [[Category:Oral medications]] | ||
[[Category:Emesis prevention]] | [[Category:Emesis prevention]] | ||
[[Category:Serotonin 5-HT3 antagonists]] | [[Category:Serotonin 5-HT3 antagonists]] | ||
| − | [[Category: | + | [[Category:FDA approved in 1997]] |
Latest revision as of 15:24, 30 July 2020
Mechanism of action
5-HT3 antagonist
Also known as
- Generic name: dolasetron mesylate
- Brand name: Anzemet